- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Hepatitis B Infection in Australia
Total 499 results
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
-
Boehringer IngelheimWithdrawnHepatitis C, ChronicAustralia, Spain, Sweden
-
GlaxoSmithKlineCompletedHepatitis B | Hepatitis AAustralia
-
GlaxoSmithKlineCompletedHepatitis B | Hepatitis AAustralia, Belgium, Spain
-
Arrowhead PharmaceuticalsCompletedHepatitis BAustralia, Hong Kong, New Zealand
-
Syneos HealthF-star Therapeutics, Inc.CompletedHepatitis C InfectionAustralia, New Zealand
-
Kirby InstituteWithdrawn
-
Kirby InstituteRecruitingHepatitis BAustralia
-
GlaxoSmithKlineCompletedHepatitis BAustralia, Belgium
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Australia, Belgium, Canada, France, New Zealand, Singapore, South Africa, Vietnam
-
Bristol-Myers SquibbCompletedHepatitis B VirusAustralia, France, Germany, Korea, Republic of, Taiwan, United States, Canada, Italy, Netherlands, Singapore, Hong Kong
-
ZymoGeneticsBristol-Myers SquibbUnknownHepatitis C, ChronicAustralia, France, Poland, United States, Spain, Germany, Romania, Canada, Austria, Italy, Puerto Rico
-
Gilead SciencesTerminatedHepatitis C Virus InfectionUnited States, United Kingdom, Australia, Germany, Italy, New Zealand, Belgium, Poland, Russian Federation
-
Gilead SciencesCompletedChronic Hepatitis CIsrael, United Kingdom, Australia, Spain, Canada, New Zealand
-
Markus Peck-RadosavljevicMedical University of ViennaCompletedHepatitis C, Chronic | HIVAustria
-
Janssen Infectious Diseases BVBAVertex Pharmaceuticals IncorporatedCompletedGenotype 1 Chronic Hepatitis C | Treatment NaiveUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Spain, Sweden, Brazil, Austria, Ireland, Mexico
-
GlaxoSmithKlineCompleted
-
Gilead SciencesTerminatedHepatitis C Virus InfectionFrance, Spain, United States, Australia, Canada, Germany, United Kingdom, Italy, New Zealand, Puerto Rico
-
Kirby InstituteRecruitingHepatitis C | Hepatitis C, ChronicAustralia
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedHepatitis BBelgium, Ukraine, Australia
-
GlaxoSmithKlineCompleted
-
Viravaxx AGGouya Insights; KKS MedUni ViennaRecruiting
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis CAustria, France, Germany, United Kingdom
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France
-
Kirby InstituteMerck Sharp & Dohme LLCCompletedHepatitis C, ChronicAustralia, Canada, United Kingdom, Belgium, Germany, Norway, Switzerland
-
Presidio Pharmaceuticals, Inc.CompletedHepatitis C, ChronicUnited States, Australia, New Zealand
-
Bausch Health Americas, Inc.CompletedChronic Hepatitis CUnited States, Spain, Italy, Australia, Canada, Poland, Puerto Rico, Russian Federation, Argentina, France, Israel, United Kingdom
-
Hoffmann-La RocheCompleted
-
Foundation for Innovative New Diagnostics, SwitzerlandUNITAIDCompletedHepatitis C, ChronicAustralia, Cameroon, Georgia, Greece, Rwanda
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States, Canada, Australia, France, Germany, Austria, Italy
-
Kirby InstituteCompleted
-
Gilead SciencesCompletedChronic HCV InfectionBelgium, Austria, New Zealand, United Kingdom, Germany, Spain, Netherlands, France, Switzerland, Canada, Australia, Italy
-
Janssen-Cilag International NVCompletedHepatitis C, Chronic | InfectionUnited Kingdom, Germany, Spain, Belgium, Saudi Arabia, Austria, France
-
Gilead SciencesCompletedChronic Hepatitis CUnited States, Germany, Australia, United Kingdom, France, Netherlands, Canada, New Zealand, Italy, Poland, Austria, Estonia, Spain, Sweden, Puerto Rico, Czech Republic
-
Kirby InstituteNot yet recruiting
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France, Puerto Rico
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States, Canada, Slovakia, Poland, New Zealand, France, Australia
-
GlaxoSmithKlineCompletedHepatitis BAustralia, Czech Republic, Germany, Italy, Netherlands, Switzerland, United Kingdom
-
GlaxoSmithKlineCompletedHepatitis BAustria, Belgium, Denmark, Iceland
-
Kirby InstituteCompletedHepatitis C, ChronicUnited States, United Kingdom, Australia, France, New Zealand, Canada, Switzerland, Germany
-
Hoffmann-La RocheCompleted
-
Human Genome Sciences Inc.NovartisCompletedChronic Hepatitis CUnited States, Spain, Canada, France, Australia, Italy, Israel, Poland, United Kingdom, Germany, Czech Republic, Romania, Austria, India, Puerto Rico
-
Tibotec BVBACompletedChronic Hepatitis CFrance, Spain, Belgium, Germany, Austria, Netherlands
-
Bristol-Myers SquibbCompletedHepatitis CArgentina, Australia, Belgium, France, Germany, Italy, United States, Canada, Spain, Mexico, Austria, Poland, Netherlands, Korea, Republic of, Puerto Rico, New Zealand, Finland, Greece, Romania
-
Human Genome Sciences Inc.CompletedHepatitis C, ChronicCanada, Australia, Israel, Germany, Czech Republic, France, Poland, Romania
-
Hoffmann-La RocheCompleted
-
NovartisHuman Genome Sciences Inc.CompletedChronic Hepatitis CTaiwan, Germany, Greece, Italy, Spain, United Kingdom, France, Canada, Australia, India, Poland, Thailand
-
Human Genome Sciences Inc.NovartisCompletedChronic Hepatitis CKorea, Republic of, United States, Spain, Canada, France, Australia, Israel, Singapore, Thailand, Malaysia, Sweden, Belgium, Germany, Taiwan, Poland, Argentina, India, Puerto Rico, Brazil, Mexico, United Kingdom